Decline in forced vital capacity in subjects with systemic sclerosis-associated interstitial lung disease in the senscis trial compared with healthy reference subjects

HIGHLIGHTS

• who: Toby M. Maher from the Keck School of Medicine, University of Southern California, Los Angeles, CA, USA have published the article: Decline in forced vital capacity in subjects with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial compared with healthy reference subjects, in the Journal: (JOURNAL)
• what: These analyses comparing baseline FVC and decline in FVC in the SENSCIS trial with a hypothetical group of matched healthy individuals show that the subjects in the SENSCIS trial, who were enrolled based on an extent of fibrotic ILD on HRCT of u2265 10% but . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.